VLO
40
-2
HPE
68
-5
NWL
57
3
TRIP
52
2
RF
63
2
DLTR
58
3
VZ
39
2
CPB
37
2
CRM
59
-11
EL
59
-2
ZTS
25
2
UPS
40
2
ZBH
45
3
VIX
19
-2
STZ
49
2
DVN
40
-2
BK
77
2
STT
67
2
SWKS
56
8
A
46
2
VLO
40
-2
HPE
68
-5
NWL
57
3
TRIP
52
2
RF
63
2
DLTR
58
3
VZ
39
2
CPB
37
2
CRM
59
-11
EL
59
-2
ZTS
25
2
UPS
40
2
ZBH
45
3
VIX
19
-2
STZ
49
2
DVN
40
-2
BK
77
2
STT
67
2
SWKS
56
8
A
46
2
Financhill
Back

State Street SPDR Bloomberg 3-12 Month T-Bill ETF Vs. Travere Therapeutics, Inc. Industry Stock Comparison

Sell
6

BILS
State Street SPDR Bloomberg 3-12 Month T-Bill ETF

Last Price:
$99.15
Seasonality Move:
-0.05%
Buy
80

TVTX
Travere Therapeutics, Inc.

Last Price:
$40.3200
Seasonality Move:
33.23%
Sell
6
State Street SPDR Bloomberg 3-12 Month T-Bill ETF (BILS) is a Sell

Is State Street SPDR Bloomberg 3-12 Month T-Bill ETF a Buy, Sell or Hold?

  • The current State Street SPDR Bloomberg 3-12 Month T-Bill ETF [BILS] share price is $99.15. The Score for BILS is 6, which is 88% below its historic median score of 50, and infers higher risk than normal.
  • BILS is currently trading in the 0-10% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing an extreme reading that indicates risk could be especially high.
Buy
80
Travere Therapeutics, Inc. (TVTX) is a Buy

Is Travere Therapeutics, Inc. a Buy, Sell or Hold?

  • The current Travere Therapeutics, Inc. [TVTX] share price is $40.2800. The Score for TVTX is 80, which is 60% above its historic median score of 50, and infers lower risk than normal.
  • TVTX is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

BILS Stock Price Chart

What is State Street SPDR Bloomberg 3-12 Month T-Bill ETF's stock price today?

  • The State Street SPDR Bloomberg 3-12 Month T-Bill ETF share price today is $99.15
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and BILS is experiencing buying pressure, which is a positive indicator for future bullish movement.

TVTX Stock Price Chart

What is Travere Therapeutics, Inc.'s stock price today?

  • The Travere Therapeutics, Inc. share price today is $40.2800
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and TVTX is experiencing slight buying pressure.

BILS Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.05 Sell
Relative Strength Index (14 RSI): 37.71 Sell
Chaikin Money Flow: 0 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (99.2 - 99.42) Sell
Bollinger Bands (100): (99.24 - 99.44) Sell

TVTX Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 9.67 Buy
Relative Strength Index (14 RSI): 69.35 Buy
Chaikin Money Flow: 1508490 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (34.0318 - 36.4718) Buy
Bollinger Bands (100): (20.7309 - 34.2909) Buy

BILS Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 99.26 Sell
20-day SMA: 99.29 Sell
50-day SMA: 99.34 Sell
200-day SMA: 99.31 Sell
8-day EMA: 99.21 Sell
20-day EMA: 99.27 Sell
50-day EMA: 99.31 Sell
200-day EMA: 99.32 Sell

TVTX Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 35.7 Buy
20-day SMA: 35.23 Buy
50-day SMA: 33.43 Buy
200-day SMA: 22.2 Buy
8-day EMA: 28.52 Buy
20-day EMA: 16.32 Buy
50-day EMA: 7.67 Buy
200-day EMA: 2.09 Buy

State Street SPDR Bloomberg 3-12 Month T-Bill ETF Earnings Growth & BILS Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Travere Therapeutics, Inc. Earnings Growth & TVTX Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.54 per share, a decrease next quarter of $0.00 per share, an increase this year of $3.58 per share, and an increase next year of $1.08 per share.

State Street SPDR Bloomberg 3-12 Month T-Bill ETF Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Travere Therapeutics, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):